Neurocritical care diseases carry a high morbidity and mortality. Therapeutic and technological advances in neurocritical care have greatly improved the outcome of a variety of life-threatening disorders including traumatic brain injury, acute ischemic stroke, intracerebral and subarachnoid hemorrhage, and anoxic injury following cardiac arrest. These advances have stemmed from a better understanding of the physiology of neurocritical care illnesses, improved neuromonitoring techniques, and the introduction of more efficacious treatments. Despite all the advances in neuromonitoring, diagnostic imaging, and emerging treatments, much research needs to be undertaken in neurocritical care. Many of the clinical trials carried out in the general critical care population have excluded neurocritical care patients. For instance, the landmark ARDSNET trial that demonstrated the beneficial effects of low tidal volume ventilation in patients with ARDS cannot be directly applied to neurocritical care patients who frequently may experience this pulmonary complication. There is a need for a more cohesive and integrated research system or network to establish a track record for high-quality, investigator-initiated clinical research in neurocritical care. Such a system may help us overcome potential impediments to the future advancement of neurocritical care research. We propose the creation of the neurocritical care research network. The mission of the Network is to facilitate multicenter and multidisciplinary collaboration and patient enrollment in clinical trials of specific neurocritical care diseases.
KeywordsNeurocritical care Critical care Clinical trials Research network Consortium
- 2.Bleck T. Critical care and emergency neurology. In: Cohen MM, editor. The American academy of neurology: The first 50 years 1948–1998. St Paul: American Academy of Neurology; 1998. pp. 225–7.Google Scholar
- 3.www.neurocriticalcare.org. Accessed 1 June 2010.
- 6.www.ardsnet.org. Accessed 1 June 2010.
- 7.www.anzics.com.au/ctg. Accessed 1 June 2010.
- 8.www.ccctg.ca. Accessed 1 June 2010.
- 12.Cook DJ, Guyatt GH, Marshall J, et al., for the Canadian Critical Care Trials Group. A comparison of sucralfate and ranitidine for prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791–7.Google Scholar
- 13.Sandham JD, Hull RD, Brant RF, et al., for the Canadian Critical Care Trials Group. A randomised controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients N Engl J Med. 2003;38:5–14.Google Scholar
- 14.Cook DJ, Rocker G, Marshall J, et al., for the Level of Care Study Investigators and the Canadian Critical Care Trials Group. Withdrawal of mechanical ventilation in anticipation of death in the intensive care unit. N Engl J Med. 2003;349:1123–32.Google Scholar
- 15.Hutchison SJ, Ward RE, Lacroix J, et al., for the Hypothermia Pediatric Head Injury Trial investigators and the Canadian Critical Care Trials Group. Hypothermia Therapy Following Traumatic Brain Injury in Children. N Engl J Med. 2008;358:2447–56.Google Scholar
- 25.Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.PubMedGoogle Scholar
- 27.http://www.nett.umich.edu/nett/welcome. Accessed 1 June 2010.
- 28.Wright WL. Mapping neurocritical care units. Curr Neurocritical Care Soc Newslett. 2007;2(3):4.Google Scholar
- 29.http://www.hhs.gov/ohrp/humansubjects/guidance/hsdc97-01.htm. Accessed 1 June 2010.
- 30.http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=50.24. Accessed 8 June 2010.
- 31.http://www.neurocriticalcare.org/i4a/pages/index.cfm?pageid=3961. Accessed 8 June 2010.